zSpace, Inc. Common stock (ZSPC) Stock Forecast & Price Target
zSpace, Inc. Common stock · NASDAQ
$0.15-0.01 (-3.23%)
15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering zSpace, Inc. Common stock, 0 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $0.50 to $0.50, so the covering firms are broadly aligned. The average target of $0.50 sits 233% above the current $0.15. The rating mix has stayed broadly stable, with Buy-side ratings easing from 1 to 0 over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Hold
Strong Buy00%
Buy00%
Hold1100%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to zSpace, Inc. Common stock.
As of Aug, 0 of 1 firms rate ZSPC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ZSPC EPS & revenue forecast
EPS · NEXT QUARTER
$-0.08
Range $-0.08 – $-0.08 · 1 analysts · -99% YoY
Next period, 1 analysts expect zSpace, Inc. Common stock to earn $-0.08 a share (range $-0.08 – $-0.08), versus $-5.75 a year earlier. Full-year consensus is $-460.00.
REVENUE · NEXT QUARTER
$4.5M
Range $4.5M – $4.5M · 1 analysts · -7% YoY
Revenue is expected to reach $4.5M (range $4.5M – $4.5M), -7.2% year-over-year. Full-year consensus is $20.1M, rising to $0 next year.
Top analysts covering zSpace, Inc. Common stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ZSPC.
#1
Alexander Paris
Barrington Research · Rank #80
Hold
No targeton ZSPC
Overall win rate
54%
+ Follow
#2
Nehal Chokshi
Northland Capital Markets · Rank #342
Hold
$22.50+14900.0% to target
Overall win rate
30%
+ Follow
#3
Rohit Kulkarni
Roth MKM
Buy
$75.00+49900.0% to target
Coverage
—
+ Follow
ZSPC stock forecast FAQ
Is ZSPC stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 1 analyst ratings, 0 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover ZSPC?+
1 analysts have an active rating on zSpace, Inc. Common stock.
Who is the most accurate analyst covering ZSPC?+
Among analysts who currently cover ZSPC, Alexander Paris of Barrington Research has the strongest overall Quantellect track record (Rank #80). Their current call is Hold.
What is zSpace, Inc. Common stock's projected EPS for next quarter?+
The consensus estimate is $-0.08 per share (range $-0.08 – $-0.08) across 1 analysts. Full-year EPS is projected at $-460.00, rising to — the following year.
How much revenue is zSpace, Inc. Common stock expected to report next quarter?+
Consensus revenue is $4.5M (range $4.5M – $4.5M). Full-year revenue is projected at $20.1M, growing to $0 next year.
Have analysts been upgrading or downgrading ZSPC lately?+
As of Aug, 0 of 1 firms rate ZSPC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ZSPC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
